Key strengths

Fluofarma High Content Screening technology is a reliable strategy to combine cell-based assays with high throughput analysis. 

Fluofarma HCS key strengths


With Fluofarma High Content Screening:

► Choose reliability at high speed
► Reduce the number of false positive hits
► Identify beyond doubt the right lead
► Understand the mechanism of action of your compounds  

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Cell Research.

    Read more [+]

  • Publication

    Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”

    Read more [+]

  • Press Release

    Roche adopts Fluofarma’s high-content screening platform.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".

    Read more [+]

  • AACR 2010

    Fluofarma will be exhibitor at AACR 2010, in Washington from April 17th to 21st.

    Read more [+]

  • WPC 2010

    Fluofarma will be exhibitor at World Pharmaceutical Congress 2010, in Philadelphia from June 15th to 17th.

    Read more [+]

Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into a multi-year agreement with Roche.
Read More